The aim of this study was to evaluate whether remote ischaemic preconditioning (RIPC) combined with remote ischaemic postconditioning (RIPostC) improves the clinical outcomes of patients undergoing cardiac surgery.
Introduction
Brief sublethal ischaemia activates a robust protective system against ischaemic reperfusion injury for a specific time window. Following the first identification of ischaemic preconditioning by Murry et al., 1 ischaemic preconditioning has been shown to provide powerful protective effects on ischaemic reperfusion injury in animal 2, 3 and in vitro 4, 5 studies. Given the predictive time window for ischaemic reperfusion injury, ischaemic preconditioning seemed to be particularly suitable in cardiac surgeries during which ischaemic reperfusionrelated complications are frequent. 6, 7 However, ischaemic preconditioning is an invasive technique using repeated aorta cross-clamp or coronary artery occlusion. 7, 8 There have been continued trials to improve the classic ischaemic preconditioning technique.
In early clinical studies, remote ischaemic preconditioning (RIPC) showed impressive results. 9 -11 In RIPC, brief sublethal ischaemia applied to remote organs or tissues induced systemic protection and significantly attenuated postoperative troponin elevation in cardiac 9, 10 and non-cardiac 11 surgery patients. The RIPC techniques used in these studies were very simple, inexpensive, and non-invasive. Remote ischaemic preconditioning is considered a promising cardioprotective technique for cardiac surgery patients. However, there have been some contradictory results, in which RIPC did not reduce perioperative troponin release. 12 -14 Although RIPC is expected to exert a systemic protective effect, several studies of the effect of RIPC on renal failure have failed to show a significant benefit. 14, 15 In the present study, we hypothesized that RIPC with RIPostC (remote ischaemic postconditioning) would improve clinical outcomes by decreasing perioperative complications in patients undergoing cardiac surgery. To evaluate this hypothesis, we conducted a prospective randomized controlled study in patients undergoing cardiac surgery.
Methods Patients
The present study was conducted at two tertiary care centres (Seoul National University Hospital and Asan Medical Centre) from June 2009 to November 2010. The study protocol was approved by each Institutional Review Board and written informed consent was obtained from all patients. We enrolled patients from age 18 to 80 years undergoing elective cardiac surgery, including cardiac valve surgery, coronary artery bypass grafting surgery (CABG), combined valve, and CABG surgery, ascending aorta or aortic arch surgery, and congenital heart defect repair. Exclusion criteria were as follows: emergent or urgent operation, a left ventricular ejection fraction ,30%, preoperative use of an inotropic agent or a mechanical assist device, severe hepatic, renal, or pulmonary disease, recent myocardial infarction (MI) within 7 days, recent systemic infection or sepsis (within 7 days), peripheral vascular disease affecting the upper limbs, descending thoracic aortic surgery, and rare surgeries such as cardiac transplantation, correction of complicated congenital anomalies, and pulmonary thromboendarterectomy.
Randomization and remote ischaemic preconditioning with remote ischaemic postconditioning technique
Eligible patients were randomly allocated to either the RIPC with RIPostC group or the control group using a computer-generated list. The randomization list was generated by an independent statistician and was stored in concealed envelopes. The group assignment was performed in the morning of the surgery and was blinded to all patients, medical personnel, and investigators. The anaesthesia nurses, who performed the RIPC with RIPostC process, were not involved in clinical care of the patients.
In the RIPC with RIPostC group, a blood pressure cuff was placed around the upper arm. The cuff was inflated to 200 mmHg for 5 min and deflated for 5 min. This inflation-deflation cycle was repeated four times. This inflation-deflation protocol was applied twice immediately after induction of anaesthesia before cardiopulmonary bypass (CPB) or coronary anastomoses for RIPC, and immediately after the completion of CPB or coronary anastomoses for RIPostC. The patients in the control group had the same pneumatic cuff around the upper arm and similar manoeuvres were performed, but pressure was not applied to the cuff because the three-way stopcock between the cuff and cuff inflator was opened. Figure 1 illustrates details of the study protocol per randomization group.
Treatment
On arrival in the operating room, the patients were sedated with i.v. midazolam. Anaesthesia was induced with i.v. midazolam, etomidate, and sufentanil, and maintained with propofol (0.04-0.07 mg/kg/min) and remifentanil (0.5-1.0 mg/kg/min). An inhalation agent was not used to avoid any pharmacological preconditioning effect. Muscle relaxation Figure 1 Study protocol. RIPC, remote ischaemic preconditioning; RIPostC, remote ischaemic postconditioning. Does remote ischaemic preconditioning with postconditioning improve clinical outcomes? was obtained using vecuronium. After tracheal intubation, lungs were mechanically ventilated, and ventilation was adjusted to achieve an endtidal carbon dioxide tension of 35 -40 mmHg. The patients were monitored continuously by five-lead electrocardiography, pulse oximetry, and transoesophageal echocardiography and were checked for nasopharyngeal temperature, invasive arterial pressure, and pulmonary artery pressure.
In on-pump surgeries, the patients underwent cardiac surgery using non-pulsatile CPB technique with a membrane oxygenator and cardiotomy suction. Cardiac protection was achieved using antegrade or retrograde cold-blood cardioplegia. Heparin was administered before CPB or coronary anastomoses and was reversed by protamine after discontinuing CPB or completion of anastomoses. At the end of surgery, patients were transferred to the intensive care unit (ICU).
Study outcomes
The primary study endpoint was a composite of major adverse outcomes that included in-hospital death, MI, arrhythmia requiring treatment, stroke, coma, renal failure or dysfunction, respiratory failure, cardiogenic shock, gastrointestinal complication, and multiorgan failure. A patient experiencing more than one single event was counted only once in the composite outcome.
The diagnosis of MI was based on the development of new Q waves or new persistent ST-T change associated with cardiac biomarker values more than five times the upper reference limit. 16 Arrhythmia was defined to contain ventricular fibrillation, tachycardia, and atrial fibrillation requiring treatment. Stroke was defined as a new ischaemic or haemorrhagic cerebrovascular accident with neurological deficit lasting .24 h. Coma was defined as a profound or deep state of unconsciousness lasting .24 h. Renal failure was defined as the new requirement of dialysis treatment and renal dysfunction as postoperative serum creatinine of .2.0 mg/dL accompanied by an increase of creatinine of at least 0.7 mg/dL from the preoperative baseline. Respiratory failure was defined as the need for postoperative mechanical ventilation for .72 h. Cardiogenic shock was defined as the use of inotropic agents, vasopressors, or a mechanical assist device for .72 h. Gastrointestinal complication was defined as gastrointestinal bleeding requiring transfusion, pancreatitis requiring nasogastric suction, cholecystitis requiring drainage, or mesenteric ischaemia requiring exploration. Multiorgan failure was defined as compromised functioning of two or more major organ systems. Major organ systems are neurological, renal, pulmonary, cardiac, vascular, and systemic. Secondary study endpoints were the length of ICU and hospital stays. The duration of hospital stay was defined as the difference in days between the discharge date and surgery date.
Statistical analysis
We hypothesized that the RIPC with RIPostC group would have less composite outcomes than the control group. The sample size was determined based on the rate of composite outcome at Seoul National University Hospital and Asan Medical Centre, which was 40.3% in 2008. To detect a 20% relative reduction of composite outcome, the study required 584 patients in each group at a power of 80% with a twosided significance level of 0.05. Considering the non-compliance rate and follow-up loss, we decided to enrol a number of patients 15% greater than the calculated sample size, resulting in 688 patients per group.
Patients were stratified according to the type of surgery (with or without CPB) and hospital. Within each of these strata, randomization was performed using sequenced blocks of four or six to ensure balance between the randomization groups. Data for all enrolled patients were included in the analysis of the primary and secondary endpoints, according to the intention-to-treat principle. Baseline characteristics of the patients were assessed using frequency distributions and univariate descriptive statistics.
For our primary analyses, we compared the composite outcome of two groups using the x 2 test. The rates of adverse events were also compared using the x 2 test. Multivariate logistic regression with a forward stepwise algorithm was performed to adjust risk factors for the composite outcome. A significance level of 0.05 is used to enter a variable into the model and to remove it from the model. For the secondary outcomes of ICU and hospital stays, the differences between the two groups were assessed using the Mann-Whitney U test. Postoperative characteristics were compared with the Mann-Whitney U test or x 2 test.
A P-value , 0.05 was deemed to indicate statistical significance. We performed prespecified subgroup analyses by the use of CPB. In each subgroup, multivariate logistic regression analysis was performed to adjust risk factors for the composite outcome. Post hoc subgroup analyses were performed, and interaction terms between treatment assignment and potential risk factors were obtained using logistic regression analysis.
Statistical analysis was performed using SPSS Statistics ver.17.0 (SPSS, Inc., Chicago, IL, USA) and SAS (2002 -2003 by the SAS Institute, Inc., Cary, NC, USA) for Microsoft Windows.
Results

Study population
Of the 1617 patients who underwent screening, 243 did not meet the eligibility criteria (Figure 2 ). Of the 1374 eligible patients, 46 did not undergo randomization because 32 refused consent, and 14 were decided to postpone or cancel the surgery before randomization. Of the 1328 randomized patients, 48 were excluded because 17 withdrew consent after surgery, 9 received preoperative inotropic support, 10 underwent ineligible surgery, and 12 did not undergo surgery. Although 22 patients did not meet the inclusion criteria, they were included in the analysis based on the intention-totreatment principle. Finally, 1280 patients were included in the intention-to-treatment analysis-644 in the RIPC with RIPostC group and 636 in the control group. The two groups were balanced with regard to most baseline characteristics ( Table 1) . Adverse events caused by the RIPC with RIPostC technique itself were not reported.
Primary composite endpoints
There was no significant difference between the RIPC with RIPostC and the control group in the rate of composite outcomes (38.0 vs. 38.1%, respectively; P ¼ 0.998). The rate of in-hospital mortality after surgery was 1.6% in the RIPC with RIPostC group and 2.2% in the control group (P ¼ 0.392). The rates of adverse events, including MI, arrhythmias, stroke, respiratory failure, gastrointestinal complication, and multiorgan failure, were not significantly different between the two groups ( Postoperative characteristics, such as postoperative inotropic support, mechanical ventilation time, and the use of a mechanical assist device, were comparable between the groups. Transfusion requirements were also comparable between the groups ( Table 3) .
Subgroup analyses
Rates of composite outcomes were compared among the various major subgroups ( Table 4 ). There was a trend for interaction between the use of CPB and the RIPC with RIPostC (P ¼ 0.053).
Subgroup analyses were performed in terms of the use of CPB. Multivariate logistic regression analysis with adjustment for covariables revealed that RIPC with RIPostC did not decrease the composite outcome (adjusted OR: 0.87; 95% CI: 0.64-1.16; P ¼ 0.337). However, in patients who underwent OPCAB, multivariate logistic regression analysis revealed that RIPC with RIPostC was associated with an increased composite outcome (adjusted OR: 1.54; 95% CI: 1.02-2.30; P ¼ 0.038).
Postoperative complications and characteristics were compared separately in terms of the use of CPB. Among the patients who underwent OPCAB, the patients in the RIPC with RIPostC group received more RBC than those in the control group: 2 units (IQR: 1-3 units) vs. 1 unit (IQR: 0.5 -2 units), respectively (P ¼ 0.001).
Discussion
The main findings of the present study are as follows; RIPC with RIPostC did not reduce the composite of major adverse outcomes compared with the control group (38.0 vs. 38.1%, respectively; P ¼ 0.998). There were no differences in major postoperative outcomes, including death, cardiac, respiratory, neurologic, renal and gastrointestinal complications. The ICU and hospital stays were comparable between the two groups. However, in OPCAB patients, RIPC with RIPostC was related to increased composite outcome (OR: 1.54; 95% CI: 1.02-2.30; P ¼ 0.038). These results suggest that RIPC does not to improve the clinical outcome of cardiac surgery patients.
Remote ischaemic preconditioning effect
The effect of RIPC in preventing ischaemia-reperfusion injury has been investigated in patients undergoing cardiac surgery and percutaneous coronary intervention; however, results are conflicting. In early clinical studies, RIPC markedly reduced postoperative myocardial enzyme levels in cardiovascular surgery patients, 9 -11,17 which resulted in RIPC receiving more attention. Several studies of RIPC were subsequently conducted: in a recent meta-analysis, RIPC yielded a statistically significant reduction in troponin levels in cardiovascular surgery patients. 18 However, RIPC has not always been successful in decreasing postoperative myocardial enzyme elevation.
-14
Remote ischaemic preconditioning is thought to have systemic protective effects on distal organs including the heart, lungs, and kidneys. Several studies have investigated the effect of RIPC on renal failure, but the protective effect is controversial. Remote ischaemic preconditioning reduced the incidence of renal impairment in aortic surgery patients, 11 but failed to improve renal function in other studies.
14,15,18
Interpretation of the results
There are several plausible explanations for the negative results we report here. We did not control for all the factors that may influence the protective effect of the RIPC technique. We used propofol for maintenance of anaesthesia in the present study. In a recent RIPC study by Kottenberg et al., 19 RIPC induced a cardioprotective effect only under isoflurane anaesthesia; this effect was abrogated by propofol. The authors speculated that propofol, a scavenger of oxygenfree radicals, may interfere with the protective effect of RIPC. 20 However, in other previous studies, RIPC showed cardioprotective effects with propofol 15 but not with volatile anaesthetics. 12, 13 Moreover, in our study, the dose of propofol (0.04-0.07 mg/kg/min) used was lower than that in the study of Kottenberg et Continuous data are reported as means + SD or median (inter-quartile range). RIPC, remote ischaemic preconditioning; RIPostC, remote ischaemic postconditioning; NYHA, New York Heart Association; ASA, American Society of Anesthesiologist; CABG, coronary artery bypass graft surgery; OPCAB, off-pump coronary bypass graft surgery. The protective effect of RIPC might be attenuated by its undesirable effect, which is at least partially supported by the increased amount of transfusion in the RIPC with RIPostC group who underwent OPCAB in the present study. The risks associated with the RIPC technique have not been reported previously; indeed, it is considered to be relatively non-invasive and safe. 21, 22 However, transient tourniquet inflation on the limb can have significant and complex effects on the systemic coagulation and inflammation systems. 23, 24 Tissue ischaemia caused by tourniquet inflation promotes the release of tissue plasminogen activator, leading to systemic thrombolysis when the tourniquet is released. 25 Moreover, for patients with coronary artery disease, the RIPC technique reduces the exercise-related increase in platelet reactivity; 26 
Limitations of the study
We enrolled the majority of adult cardiac surgery patients; thus our findings would reflect the actual clinical situation. Consequently, the present study population included both on-and off-pump cardiac surgery patients, but our results indicated that the effects of RIPC with RIPostC might differ between these patients. However, subgroup analysis increases the likelihood of type I error. Therefore, the subgroup analysis results, such as the increase in composite outcome and RBC transfusion in OPCAB, may not have reached statistical significance. These topics may be more clearly answered by the RIPHeart study 27 Remote ischaemic postconditioning was added to RIPC based on the results of our previous studies, which revealed that the use of the RIPC combined with a RIPostC protocol indicated a significant reduction in postoperative myocardial enzyme elevation, 15 whereas use of the isolated RIPC protocol had no significant effect on the degree of reduction in myocardial enzyme elevation during the postoperative period.
12 This is consistent with previous animal 29 and clinical studies, 30 in which preconditioning and postconditioning showed additive protective effects. We believe that this phenomenon augmented the protective effect. However, our results might not be applicable to the RIPC technique without RIPostC.
In conclusion, RIPC with RIPostC did not reduce the incidence of perioperative complications, or the duration of ICU or hospital stay in the present study. Remote ischaemic postconditioning with RIPostC by transient upper limb ischaemia does not improve the clinical outcomes of cardiac surgery patients.
